Latest News

Symcel’s new engineer is increasing production and R&D capacity

Published Feb 4, 2019

2018 saw Symcel growing as never before, evolving from two members to a fully fledged 9-people team. As we dynamically entered the market and demands to increase production of our

Learn more

Antibiotic resistance – current landscape and combination therapy

Published Sep 27, 2018

Why is antibiotic resistance a global threat? The challenges of antibiotic resistance, the current situation that marks it as a WHO priority and the potential of customized therapy are some

Learn more

Brown fat treatment research using isothermal microcalorimetry

Published Sep 5, 2018

Our colleague Dr. Karin Gillner recently had a feature article on brown fat treatment research published in Journal for Clinical Studies.   Karin showcased how isothermal microcalorimetry can be a solution

Learn more

New board members bolstering expansion into diagnostics market

Published Jun 27, 2018

Symcel appoints two new board members to bolster R&D business growth and expansion into the clinical diagnostics market   L: Stefan Löfås, R: Erik Walldén  June 27 2018: Symcel – the company

Learn more

Karolinska Institutet to clinically validate calScreener™ for AST

Published Apr 11, 2018

Internationally renowned clinical microbiologist takes academic lead in Horizon 2020 funded validation of game-changing method for multiple antibiotic resistance evaluation 11 April 2018: Symcel – the company behind the revolutionary

Learn more

Symcel expands staff to promote clinical market growth

Published Feb 7, 2018

L-R: Dr Marta Veses Garcia, Pelle Friberg and Dr Karin Gillner   Symcel – producers of the cell-based assay tool for real-time cell metabolism measurements, calScreener — is expanding to

Learn more

Symcel Secures €3.6M for Antibiotic Susceptibility Testing

Published Nov 21, 2017

Symcel secures €3.6 million Horizon 2020 Phase II grant for clinical validation of customized antimicrobial susceptibility testing. Multi-resistant bacterial sepsis infections to be validated utilising Symcel’s sensitive screening technology Symcel:

Learn more

Jesper Ericsson appointed new CEO of Symcel

Published Nov 1, 2017

Symcel AB today announces the appointment of Jesper Ericsson as new Chief Executive Officer – succeeding Christer Wallin who is now retiring. 1 September 2017: Symcel has today announced that

Learn more